Organization
Orbimed Israel Partners LP
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Orbimed Israel Partners LP
... Arix Bioscience led the round with participation from other investors that included OrbiMed, Edmond De Rothschild Investment Partners, Pontifax, SBI and OrbiMed Israel Partners. In ...
... Bioscience led the oversubscribed round in the semi-stealth biotech, with new investors OrbiMed, Edmond De Rothschild Investment Partners, Pontifax, and SBI, along with previous investors ...
... in financing to date. The investments were led by Arix Biosciences and OrbiMed. Edmond de Rothschild Investment Partners, Pontifax, and SBI Japan-Israel Innovation Fund also ...
... of the world's leading healthcare organizations: Johnson & Johnson Innovation, Takeda, and OrbiMed, in cooperation with the Israel Innovation Authority (formerly the Office of the ...
... Israeli startup on Wednesday as it develops next-generation cell immunotherapies for cancer. OrbiMed led the Series A round with participation from Novartis Venture Fund and ...
... develops immunotherapies directed to the intracellular proteome. The financing was led by OrbiMed and also included Novartis Venture Fund and Pontifax. "These significant financial resources ...
... Biopharmaceutical company SmartZyme has raised $4 million in funding from OrbiMed. In conjunction with the director, SmartZyme has added Dr. Nissim Darvish, senior ...
... to try to raise $250 million ( 235 million) without state support. OrbiMed Israel Senior Managing Director Dr. Nissim Darvish Globes broke news of the ...
... the next eight years. FutuRx was established through a collaboration among OrbiMed Israel Partners, Johnson & Johnson Innovation - JJDC, and Takeda Pharmaceutical Company, through ...
... established during the next eight years. FutuRx was incorporated jointly by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC), ...
... Office of the Chief Scientist in Israel, Takeda Pharmaceutical Company, and OrbiMed Israel Partners, is a public-private biotechnology incubator that will be located near the ...
... to help finance its development of drugs to treat gastrointestinal conditions. OrbiMed Israel Partners LP agreed to buy 631,580 units for $9.50 each in the ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤